Top Markets
#1 Cash Cat Cash Cat +12.09%
#2 Siacoin Siacoin +11.51%
#3 0G 0G +9.75%
#4 Seeker Seeker +9.52%
#5 Arbitrum Arbitrum +8.67%
#6 Metis Metis +5.28%
#7 Story Story +3.96%
#8 MarsCoin MarsCoin +3.88%
#9 Cryptopia Cryptopia +3.87%
#10 Metronome Synth ETH Metronome Synth ETH +3.75%
Coin of the day
Cash Cat Cash Cat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Rangering i aksjer #14047
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Aksjekurs
$0.88012714
Sist synkronisert: 2026-08-31
Markedsverdi
$439.58M
Endring (1 dag)
-4.01%
Endring (1 år)
1,131.97%
Land
FR
Handel Valerio Therapeutics S.A. (ALVIO)

Kategori

Healthcare
Aksjeprishistorikk for Valerio Therapeutics S.A. (ALVIO)
Høyeste sluttskurs: $0.91 den 2026-08-01

Laveste sluttskurs: $0.28 den 2023-06-01
Aksjeprishistorikk for Valerio Therapeutics S.A. fra 2023 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 53.06%
2025 116.87%
2024 -58.47%
2023 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.58 -11.06%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.10%
CH